ARCHIVES

Zaltrap Receives Positive Opinion For European Market From CHMP

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

Cancer Information Service Marks 20th anniversary

April 4, 1996

Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients

December 28, 2012

Unscreened Women At High Risk of Breast Cancer

October 29, 2004

In Brief: Henderson Chairs Reorganized NCA Centers Subcommittee; Core Grant Guidelines On Agenda

August 22, 1980

Surveillance Treatment Option For Low-Risk Prostate Cancer

July 30, 2010

Funding Opportunities

September 27, 2002